Lamin
Lamin is an open data platform that helps biology teams unify, validate, and share experimental data and predictive models. It provides an open-source, API-first framework combining a lakehouse, data lineage, feature store, ontology and bio-registry management, and integrations with workflow managers. The platform uses distributed databases and Python APIs to transform artifacts into queryable datasets, models, and analytical outputs while enforcing validation, standardization, and metadata annotation. Offered as open-source software plus hosted SaaS and on-premises deployments, it targets research teams and organizations in biology and bioinformatics.
Lamin
Lamin is an open data platform that helps biology teams unify, validate, and share experimental data and predictive models. It provides an open-source, API-first framework combining a lakehouse, data lineage, feature store, ontology and bio-registry management, and integrations with workflow managers. The platform uses distributed databases and Python APIs to transform artifacts into queryable datasets, models, and analytical outputs while enforcing validation, standardization, and metadata annotation. Offered as open-source software plus hosted SaaS and on-premises deployments, it targets research teams and organizations in biology and bioinformatics.
TL;DR
What they do: Open-data, lineage-native lakehouse and platform (LaminDB) for biological R&D
Founded: 2022
Headquarters: Munich, Germany and New York City, USA
Product model: Open-source software plus hosted SaaS and on-premises deployments
Recent disclosed funding: $25M (seed + Series A, most recent round reported May 2024)
Company Overview
Problem Domain
Biological R&D data management, dataset lineage, validation, cataloging, and organizational memory for research workflows.
Founded
2022
Industry
DeepTech
Tech Stack
Funding Track Record
$25M (total disclosed across seed and Series A)
Most recent funding round publicly reported May 2024; $25M disclosed as total across rounds.
Company page lists a funding-related date entry; specific amount and lead not stated in provided evidence.
Investor Signal
“Mixed institutional and prominent angel backing including individual investors named on company pages and reported participation from investors such as Amplify, Dimension Capital, Y Combinator, Jeff Hammerbacher, Aaron Kimball, Alec Nielsen, Oskari Saarenmaa”